Kiniksa Pharmaceuticals, Ltd. (KNSA)

USD 21.47

(-1.74%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 526.32 Million 459.67 Million 232.8 Million 349.46 Million 254.53 Million 321.96 Million
Total Current Assets 276.29 Million 243.06 Million 196.44 Million 333.24 Million 241.62 Million 313.75 Million
Cash And Short Term Investments 206.37 Million 190.6 Million 182.2 Million 323.48 Million 233.38 Million 307.3 Million
Cash and Cash Equivalents 107.95 Million 122.71 Million 122.47 Million 114.03 Million 46.92 Million 307.3 Million
Short Term Investments 98.41 Million 67.89 Million 59.73 Million 209.44 Million 186.45 Million 235.32 Million
Net Receivables 21.26 Million 20.31 Million 3.98 Million - - -
Inventory 31.12 Million 21.59 Million 3.67 Million - - -
Other Current Assets 17.53 Million 10.53 Million 6.58 Million 9.55 Million 8.24 Million 6.44 Million
Total Non-Current Assets 250.02 Million 216.61 Million 36.35 Million 16.21 Million 12.9 Million 8.21 Million
Net PPE 12.66 Million 7.04 Million 8.38 Million 10.61 Million 8.32 Million 6.35 Million
Good Will And Intangible Assets 17.25 Million 18.25 Million 19.25 Million - -210 Thousand -210 Thousand
Good Will - - - - - -
Intangible Assets 17.25 Million 18.25 Million 19.25 Million - - -
Long-Term Investments -1.00 - - - 210 Thousand 210 Thousand
Tax Assets 219.28 Million 185.49 Million - 10 Thousand 4.37 Million 1.21 Million
Other Non Current Assets 827 Thousand 5.82 Million 8.72 Million 5.58 Million 210 Thousand 643 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 87.48 Million 63.52 Million 47.76 Million 37.52 Million 29.11 Million 42.69 Million
Total Current Liabilities 63.66 Million 47.06 Million 44.82 Million 31.84 Million 27.83 Million 42.55 Million
Account Payables 8.24 Million 7.89 Million 1.86 Million 503 Thousand 5.69 Million 10.91 Million
Tax Payables - - - - - -
Short Term Debt 2.25 Million 3.3 Million 3.38 Million 2.1 Million 1.69 Million -
Deferred Revenue 307 Thousand 12 Million 38.03 Million 29.19 Million 20.41 Million -
Other Current Liabilities 52.86 Million 23.86 Million 1.54 Million 37 Thousand 25 Thousand 31.63 Million
Total Non Current Liabilities 23.81 Million 16.45 Million 2.93 Million 5.68 Million 1.28 Million 144 Thousand
Long-Term Debt 10 Million 2.61 Million 2.66 Million 4.87 Million 955 Thousand -
Deferred Revenue Non Current 11.95 Million 12 Million - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.85 Million 1.83 Million 270 Thousand 805 Thousand 326 Thousand -1.07 Million
Other Liabilities - - - - - -
Total Equity 438.83 Million -492.03 Million -675.39 Million -517.47 Million -356.09 Million -194.22 Million
Stock Holders Equity 438.83 Million -492.03 Million -675.39 Million -517.47 Million -356.09 Million -194.22 Million
Common Stock 20 Thousand 19 Thousand 18 Thousand 18 Thousand 15 Thousand 13 Thousand
Retained Earnings -477.95 Million -492.03 Million -675.39 Million -517.47 Million -356.09 Million -194.22 Million
Accumulated other comprehensive income 6000.00 44 Thousand -66 Thousand -34 Thousand 33 Thousand -4000.00
Common Stock Equity 438.83 Million -492.03 Million -675.39 Million -517.47 Million -356.09 Million -194.22 Million
Capital Lease Obligation 10 Million 5.91 Million 6.05 Million 6.98 Million 2.65 Million -
Total Investments 98.41 Million 67.89 Million 59.73 Million 209.44 Million 186.45 Million 235.32 Million
Total Debt 12.25 Million 5.91 Million 6.05 Million 6.98 Million 2.65 Million -
Net Debt -95.69 Million -116.79 Million -116.42 Million -107.05 Million -44.27 Million -307.3 Million

Balance Sheet Charts